Open Medicine Foundation (OMF) is investigating decreased mitochondrial membrane potential through the itaconate shunt hypothesis at the Collaborative Center at Stanford University.

Public source

Publisher name

Public post

Membrane potential is the difference in voltage between the inside and outside of a membrane (e.g., cell membrane, mitochondrial membrane). It’s created by concentration…

Log in to read the full post

Company

Open Medicine Foundation (OMF)

Leading research. Delivering hope.

Industry
Research Services
Location
Agoura Hills, US
Company size
11–50 employees

About Open Medicine Foundation (OMF)

Open Medicine Foundation (OMF) is leading research of chronic, complex diseases and delivering hope. Chronic diseases such as myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) and Long COVID have devastating effects on individuals and their families. OMF's goal is to bring relief and find a cure for these conditions. OMF has already raised over $50 million to fund research, treatment trials, and education for healthcare providers. We support a global team of expert scientists at seven research centers around the world, with over 55 studies already in progress.

See more

Latest activity

4 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.